$NVIDIA (NVDA.US)$「米利下げトレード」第1弾！FRBの決断と共に、バイオテック株の反攻開始！？After-hours tradingIn Decreased by 6.9%.Done.
(For information on sector rotation, please refer to the report below. August 20th)
The following three factors are believed to have led to profit-taking selling.
1) Falling short of explosive growth expectations
Q2 results exceeded market expectations. 3Q revenue guidance of 32.5 billion dollars ± 2%, surpassed the market average estimate of 31.9 billion dollars, but did not reach the bullish estimate of 37.9 billion dollars.
2) Evaluation of the impact of Blackwell delay
Demand for AI semiconductor Hopper (current product) and Blackwell (next generation product) was strong. However, the company admitted delays by changing Blackwell GPU masks to improve yield. Blackwell's revenue is expected to reach hundreds of millions of dollars in 4Q, but investors seem puzzled about how to evaluate the impact of the delay and the scale of 'hundreds of millions of dollars'. After the earnings announcement, analysts revised their performance outlook upwards.
3) Sector low...

$NVIDIA (NVDA.US)$ The earnings call for the second quarter of the fiscal year 2025 is scheduled to be held at 6:00 AM on Thursday, August 29, 2024 Japan time. This briefing It will be delivered in subtitle translation format.If you wish to watch it, "Reservation"button.
◆Precautions
The content of this live stream is provided with the subtitle translation service for the convenience of our customers. The subtitles are generated using Microsoft Azure and Amazon Translate. No explicit or implicit guarantees are made regarding the accuracy, reliability, or precision of machine translation from English to Japanese. We are not responsible for any damages resulting from the translation content. Please keep this in mind when viewing.